9-[3-[F-18]flouro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG, 2): A promising agent for monitoring HSV-tk gene transfer to tumors

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 42, Issue SUPPL. 1, 1999, Pages

  Shiue, C Y ^a   Hustinx, R ^a   Zhuang, H ^a   Shiue, G G ^a   Alavi, A A ^a   Eck, S L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gene therapy; PET; Tumors; F 18 FHPG

Indexed keywords

GENE THERAPY;

GUANINE; [F-18]FHPG;

TUMORS;

9 [(3 FLUORO 1 HYDROXY 2 PROPOXY)METHYL]GUANINE F 18; RADIOPHARMACEUTICAL AGENT; THYMIDINE KINASE; UNCLASSIFIED DRUG;

BRAIN CANCER; CANCER; CONFERENCE PAPER; DRUG SYNTHESIS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GLIOMA; HERPES SIMPLEX VIRUS; MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY;

HERPES; SIMPLEXVIRUS;

EID: 0032798003     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)